Serina Therapeutics, Inc. Common Stock SER 深 沪
已收盘 08-29 16:00:00 美东时间
5.32
+0.190
+3.70%
华盛通- 最 高5.49
- 今 开5.19
- 成交量 16.45万股
- 最 低 5.02
- 昨 收 5.13
- 总市值 5302.66万
- 52周最高 10.28
- 市盈率 静 --
- 换手率 1.65%
- 52周最低 3.81
- 委 比 -78.13%
- 总股本 996.74万
- 历史最高 209.2615
- 量 比 0.14
- 振 幅 9.16%
- 历史最低 4.10
- 每 手 1
- 风险率 0.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Marvell Technology Q2 FY2026 Earnings Call Transcript
Here is the Marvell Technology Q2 FY2026 earnings call transcript.
08-29 06:56
Serina Therapeutics Stock (SER) Soars 20% on FDA Support
Serina Therapeutics stock rallied on Tuesday after the company received a posit...
08-26 21:27
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday...
08-26 20:09
Market-Moving News for August 26th
SATS: 92% | EchoStar To Sell 3.45 GHz And 600 MHz Spectrum Licenses To AT&T For $23B, Establishes Hybrid MNO Agreement With Boost Mobile To Address FCC Inquiries IBKR: 7% | Interactive Brokers Group
08-26 19:22
Carlyle to Buy Invesco's Intelliflo for Up to $200M, Splitting UK and US Wealth Software Operations
Global investment firm Carlyle (NASDAQ:CG) and Invesco (NYSE:IVZ), a leading global asset management firm, announced today an agreement for Carlyle to acquire intelliflo from Invesco. intelliflo is a market leading
08-26 16:39
Strategy acquires 3,081 bitcoins for ~$357M in past week
Strategy (NASDAQ:MSTR) said on Monday that it acquired 3,081 bitcoins for $356.9M in the week ended August 24, compared to 430 BTC for $51.4M in the week before. Bitcoin (BTC-USD) fell 3.38% to $113,4...
08-25 20:28
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
Serina Therapeutics announced FDA support for advancing SER-252, a potential treatment for advanced Parkinson's, via a 505(b)(2) NDA pathway. The company plans to submit a U.S. IND in Q4 2025, with U.S. enrollment starting in Q1 2026 and patient dosing in Australia beginning in Q4 2025. The SER-252-1b study will evaluate safety, tolerability, and efficacy, with data from global trials supporting regulatory review. Serina's POZ platform aims to pr...
08-25 20:15
巴帕·辛哈：印度在半导体领域一度领先中韩，直到美国放了一把大火
【文/巴帕·辛哈】 在谈论数字主权之前，我想简单介绍一下印度自力更生之旅的历史背景，特别是工业自力更生，以及数字部分如何融入这个大局。 印度历史上有充满活力的自...
08-24 13:05
格斗游戏游戏哪些人气高 十大必玩格斗游戏游戏排行
探寻格斗游戏界的巅峰对决！格斗游戏游戏哪些人气高 十大必玩格斗游戏排行揭示了硬核玩家心中的经典之作。无论是街机时代的传奇《街头霸王》系列，还是现代的《拳皇》、...
08-23 18:21
先声药业2025年中报：创新药收入增长26%，经调整净利润增长21%
8月21日，先声药业（02096.HK）发布2025年中期业绩报告。2025年上半年，先声药业集团总营业收入同比增长15.1%至35.85亿元，经调整净利润6...
08-22 14:10
